Natural killer cell function in women at high risk for HIV acquisition: Insights from a microbicide trial

AIDS

Volumn 26, Issue 14, 2012, Pages 1745-1753

  Naranbhai, Vivek ^a,b,e   Altfeld, Marcus ^b,c   Abdool Karim, Quarraisha ^a,d   Ndung'U, Thumbi ^b   Abdool Karim, Salim S ^a,d   Carr, William H ^b,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

correlates of protection; herpes simplex virus; HIV infection; interferon ; natural killer cells; tenofovir gel

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN; MICROBICIDE; RECOMBINANT INTERLEUKIN 2; TENOFOVIR;

ARTICLE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; FEMALE; FLOW CYTOMETRY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEXUAL BEHAVIOR; T LYMPHOBLAST;

ADENINE; ADMINISTRATION, TOPICAL; ADULT; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CLINICAL TRIALS AS TOPIC; DISEASE SUSCEPTIBILITY; FEMALE; FLOW CYTOMETRY; HERPES GENITALIS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MIDDLE AGED; ORGANOPHOSPHONATES; RISK ASSESSMENT; SEXUAL BEHAVIOR; SOUTH AFRICA; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 84866307503     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328357724f     Document Type: Article

References (39)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. 2010. UNAIDS/10 11EjJC1958E. Geneva, Switzerland: UNAIDS.
2. Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol 2011; 40:922-930.
3. Biasin M, Clerici M, Piacentini L. Innate immunity in resistance to HIV infection. J Infect Dis 2010; 202 (Suppl 3):S361-S365.
4. Broliden K. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV-exposed seronegative individuals. J Infect Dis 2010; 202 (Suppl 3): S351-S355.
5. Lederman MM, Alter G, Daskalakis DC, Rodriguez B, Sieg SF, Hardy G, et al. Determinants of protection among HIV-exposed seronegative persons: an overview. J Infect Dis 2010; 202 (Suppl 3):S333-S338.
6. Pancino G, Saez-Cirion A, Scott-Algara D, Paul P. Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals. J Infect Dis 2010; 202 (Suppl 3):S345-S350.
7. Miyazawa M, Lopalco L, Mazzotta F, Lo Caputo S, Veas F, Clerici M. The 'immunologic advantage' of HIV-exposed ser-onegative individuals. AIDS 2009; 23:161-175.
8. Alter G, Teigen N, Ahern R, Streeck H, Meier A, Rosenberg ES, et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 2007; 195:1452-1460. (Pubitemid 46717463)
9. Addo MM, Altfeld M, Brainard DM, Rathod A, Piechocka-Trocha A, Fideli U, et al. Lack of detectable HIV-1-specific CD8(R) T cell responses in Zambian HIV-1-exposed serone-gative partners of HIV-1-positive individuals. J Infect Dis 2011; 203:258-262.
10. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, et al. HIV preferentially infects HIV-specific CD4R T cells. Nature 2002; 417:95-98. (Pubitemid 34498823)
11. Poropatich K, Sullivan DJ Jr. Human immunodeficiency virus type 1 long-term nonprogressors: the viral, genetic and im-munological basis for disease nonprogression. J Gen Virol 2011; 92:247-268.
12. Streeck H, Nixon DF. T cell immunity in acute HIV-1 infection. J Infect Dis 2010; 202 (Suppl 2):S302-S308.
13. Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol 2006; 118:1-10. (Pubitemid 43012040)
14. Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 2008; 22:595-599. (Pubitemid 351640592)
15. Jennes W, Sawadogo S, Koblavi-Deme S, Vuylsteke B, Maurice C, Roels TH, et al. Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed sero-negative female sex workers and female blood donors in Abidjan, Cote d'Ivoire. J Infect Dis 2003; 187:206-214. (Pubitemid 36132634)
16. Jennes W, Verheyden S, Demanet C, Adje-Toure CA, Vuylsteke B, Nkengasong JN, et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 2006; 177:6588-6592. (Pubitemid 44715020)
17. Montoya CJ, Velilla PA, Chougnet C, Landay AL, Rugeles MT. Increased IFN-gamma production by NK and CD3R/CD56R cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol 2006; 120:138-146. (Pubitemid 44080673)
18. Ravet S, Scott-Algara D, Bonnet E, Tran HK, Tran T, Nguyen N, et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 2007; 109:4296-4305. (Pubitemid 46743396)
19. Scott-Algara D, Truong LX, Versmisse P, David A, Luong TT, Nguyen NV, et al. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 2003; 171:5663-5667. (Pubitemid 37467178)
20. Tomescu C, Abdulhaqq S, Montaner LJ. Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin Exp Immunol 2011; 164:158-169.
21. Abdool Karim Q, Sibeko S, Baxter C. Preventing HIV infection in women: a global health imperative. Clin Infect Dis 2010; 50 (Suppl 3):S122-S129.
22. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168-1174.
23. O'Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000; 74:10074-10080.
24. Milush JM, Long BR, Snyder-Cappione JE, Cappione AJ 3rd, York VA, Ndhlovu LC, et al. Functionally distinct subsetsofhuman NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood 2009; 114:4823-4831.
25. Reinhardt C, Falk C, Steinle A, Schendel DJ. MHC class I allorecognition: the likes and dislikes of CTL and NK cells. Behring Institute Mitteilungen 1994; pp. 61-71.
26. Naranbhai V, Altfeld M, Werner L, Sibeko S, Abdool Karim Q, Abdool Karim SS, Carr WH. NK cell activation and function correlate with protection from HIV acquisition in CAPRISA004: clues to the next preventive technology? In: Conferenceon Retroviruses and Opportunistic Infections (CROI); 2011; Boston Convention Centre, Boston, Massachussetts.
27. Tiemessen CT, Shalekoff S, Meddows-Taylor S, Schramm DB, Papathanasopoulos MA, Gray GE, et al. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis 2010; 202:1444-1453.
28. Bonaparte MI, Barker E. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 2003; 17:487-494. (Pubitemid 36293101)
29. Tomescu C, Duh FM, Lanier MA, Kapalko A, Mounzer KC, Martin MP, et al. Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, unin-fected intravenous drug users. AIDS 2010; 24:2151-2160.
30. Long BR, Erickson AE, Chapman JM, Barbour JD, Vu BA, Ho EL, et al. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Immunology 2010; 129:186-196.
31. Bellner L, Thoren F, Nygren E, Liljeqvist JA, Karlsson A, Eriksson K. A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions. J Immunol 2005; 174:2235-2241. (Pubitemid 40223970)
32. Chen L, Jha P, Stirling B, Sgaier SK, Daid T, Kaul R, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One 2007; 2:e1001.
33. Corey L. Synergistic copathogens: HIV-1 and HSV-2. N Engl J Med 2007; 356:854-856.
34. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell-and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7:507-516.
35. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009; 457:557-561.
36. Maher SG, Romero-Weaver AL, Scarzello AJ, Gamero AM. Interferon: cellular executioner or white knight? Curr Med Chem 2007; 14:1279-1289. (Pubitemid 46746361)
37. Tiemessen CT, Paximadis M, Minevich G, Winchester R, Shalekoff S, Gray GE, et al. Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. J Acquir Immune Defic Syndr 2011; 57:181-189.
38. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457:722-725.
39. Ghadially H, Keynan Y, Kimani J, Kimani M, Ball TB, Plummer FA, et al. Altered dendritic cell-NK interaction in Kenyan sex workers resistant to HIV-1 infection. AIDS 2011; 26:429-436.